lorazepam has been researched along with Affective Psychosis, Bipolar in 71 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The patient was successfully treated for catatonia with lorazepam and electroconvulsive therapy after careful diagnostic workup." | 7.80 | Catatonia after deep brain stimulation successfully treated with lorazepam and right unilateral electroconvulsive therapy: a case report. ( Abbott, CC; Brodsky, A; Deligtisch, A; Evans, D; Khafaja, M; Quinn, DK; Rees, C, 2014) |
| "The authors describe four cases of catatonia in which topiramate treatment was used." | 7.73 | Topiramate effect in catatonia: a case series. ( McDaniel, WW; Sahota, AK; Spiegel, DR, 2006) |
| "Several lines of research suggested that aripiprazole might be a useful treatment for acute bipolar depression." | 5.13 | Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial. ( Bria, P; Janiri, L; Mazza, M; Pecora, RD; Squillacioti, MR, 2008) |
| " In 3 double-blind studies, acutely agitated patients with schizophrenia (N = 311), bipolar mania (N = 201), or dementia (N = 206) were treated with intramuscular (1-3 injections/24 hrs) olanzapine (2." | 5.10 | Calming versus sedative effects of intramuscular olanzapine in agitated patients. ( Alaka, K; Battaglia, J; Lindborg, SR; Meehan, K; Wright, P, 2003) |
| "Nineteen patients with bipolar disorder, manic phase, received divalproex sodium 20 mg/kg/day in divided dosages for 5 days, without other psychotropic agents except lorazepam up to 4 mg/day." | 5.07 | Valproate oral loading in the treatment of acute mania. ( Bennett, JA; Keck, PE; McElroy, SL; Tugrul, KC, 1993) |
| "We now present data from a randomized, double-blind clinical study of lorazepam versus haloperidol in 20 hospitalized patients with a DSM-III-R diagnosis of bipolar disorder who were being treated concomitantly with lithium." | 5.07 | Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study. ( Creelman, WL; Lenox, RH; Newhouse, PA; Whitaker, TM, 1992) |
| "Over 67 days, 1,461 patients were screened in the ED, 269 had bipolar I or schizophrenia, 194 of whom had a contraindication to inhaled loxapine leaving 75 eligible patients; preconsent was obtained in 43 patients." | 3.91 | Study Enrollment When "Preconsent" Is Utilized for a Randomized Clinical Trial of Two Treatments for Acute Agitation in the Emergency Department. ( Cole, JB; Driver, BE; Klein, LR; Mullinax, SZ; Nordstrom, KD; Wilson, MP, 2019) |
| "Patients with catatonia who had more than one episode of catatonia and were treated with the lorazepam-diazepam protocol were identified." | 3.83 | Relapses and recurrences of catatonia: 30-case analysis and literature review. ( Huang, TL; Hung, YY; Lin, CC; Tsai, MC, 2016) |
| "The patient was successfully treated for catatonia with lorazepam and electroconvulsive therapy after careful diagnostic workup." | 3.80 | Catatonia after deep brain stimulation successfully treated with lorazepam and right unilateral electroconvulsive therapy: a case report. ( Abbott, CC; Brodsky, A; Deligtisch, A; Evans, D; Khafaja, M; Quinn, DK; Rees, C, 2014) |
| "Analysis 1 found that nonsedated patients with bipolar I disorder and schizophrenia showed significant decreases in PEC scores following treatment with aripiprazole IM (p < 0." | 3.74 | Intramuscular aripiprazole in the control of agitation. ( Citrome, LL; Crandall, DT; Currier, GW; Manos, G; McQuade, R; Oren, D; Pikalov, AA; Zimbroff, DL, 2007) |
| "The authors describe four cases of catatonia in which topiramate treatment was used." | 3.73 | Topiramate effect in catatonia: a case series. ( McDaniel, WW; Sahota, AK; Spiegel, DR, 2006) |
| "Aripiprazole was superior to placebo in delaying time to manic relapse (p = ." | 2.73 | Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. ( Calabrese, JR; Carlson, BX; Carson, WH; Eudicone, JM; Keck, PE; Marcus, RN; McIntyre, RS; McQuade, RD; Sanchez, R, 2007) |
| " Aripiprazole was dosed flexibly up to a maximum of 30 mg daily, based on tolerability and efficacy." | 2.73 | A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression. ( Chriki, LS; Dunn, RT; Filkowski, MM; Ghaemi, SN; Stan, VA, 2008) |
| "His symptoms were consistent with catatonia, a severe motor syndrome that can be life-threatening." | 2.72 | Electroconvulsive therapy use in the adult U.S. correctional setting: A case report and literature review. ( Martin, M; Ureste, P, 2021) |
| " These findings suggest that intramuscular olanzapine is a safe and effective treatment for reducing acute agitation in patients with bipolar mania." | 2.70 | A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. ( Breier, A; David, S; Janicak, P; Koch, M; Meehan, K; Rizk, R; Small, J; Tohen, M; Tran, P; Walker, D; Zhang, F, 2001) |
| "Lorazepam 4 mg/day was insufficient to produce an advantage when added to low-dose haloperidol." | 2.69 | Acute mania: haloperidol dose and augmentation with lithium or lorazepam. ( Allen, MH; Charles, O; Chou, JC; Czobor, P; Trujillo, M; Tuma, I; Volavka, J; Winsberg, B, 1999) |
| " Serum valproate concentrations were measured three times weekly; an unblinded investigator then adjusted dosage to produce serum concentrations between 50 and 100 mg/L." | 2.67 | Valproate in the treatment of acute mania. A placebo-controlled study. ( Hudson, JI; Keck, PE; McElroy, SL; Pope, HG, 1991) |
| "Treatment with lorazepam produced marked improvement in symptomatology, while treatment with clonazepam failed to demonstrate a significant therapeutic effect." | 2.67 | Double-blind comparison of the effects of clonazepam and lorazepam in acute mania. ( Bradwejn, J; Koszycki, D; Meterissian, G; Shriqui, C, 1990) |
| "Catatonia is often a prominent feature of the syndrome." | 2.49 | Delirious mania: detection, diagnosis, and clinical management in the acute setting. ( Bobo, WV; Heckers, S; Jacobowski, NL, 2013) |
| "Catatonia is a common but often overlooked motor syndrome in child and adolescent psychiatry." | 1.43 | [Catatonia is often overlooked in child and adolescent psychiatry]. ( Ballin, NH; Pagsberg, AK, 2016) |
| "Studies in major depressive disorder have demonstrated that suprathreshold, nondominant (right) hemisphere, unilateral electrode placement ECT has fewer adverse effects, especially cognitive adverse effects, than bitemporal ECT." | 1.40 | Successful use of right unilateral ECT for catatonia: a case series. ( Conway, C; Cristancho, P; Jewkes, D; Mon, T, 2014) |
| "A 37-year-old woman presented with coma unresponsive to naloxone following topiramate ingestion." | 1.36 | Clinical effects and toxicokinetic evaluation following massive topiramate ingestion. ( Krasowski, MD; Lynch, MJ; Pizon, AF; Siam, MG, 2010) |
| " A full pharmacokinetic time profile of lithium was obtained." | 1.31 | Bayesian pharmacokinetics of lithium after an acute self-intoxication and subsequent haemodialysis: a case report. ( Beijnen, JH; Kerbusch, T; Mathôt, RA; Meesters, EW; Otten, HM; Schellens, JH; van Kan, HJ, 2002) |
| "Three patients had exceptionally high seizure threshold, as determined by an empirical titration procedure." | 1.29 | Exceptionally high seizure threshold: ECT device limitations. ( Devanand, DP; Lisanby, SH; Mullen, L; Nobler, MS; Prudic, J; Sackeim, HA, 1996) |
| "A 48-year-old, right-handed man had a cerebral infarct over the left temporal region." | 1.29 | Bipolar disorder following a stroke involving the left hemisphere. ( Fuh, JL; Liu, CY; Liu, HC; Wang, SJ; Yang, YY, 1996) |
| "The benzodiazepine withdrawal symptoms are presented here." | 1.27 | Manic-like reaction induced by lorazepam withdrawal. ( Labelle, A; Lapierre, YD, 1987) |
| " Subsequent administration of an equivalent dosage of lorazepam did not induce manic symptoms." | 1.27 | A case of alprazolam, but not lorazepam, inducing manic symptoms. ( Charney, DS; Goodman, WK, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (22.54) | 18.7374 |
| 1990's | 12 (16.90) | 18.2507 |
| 2000's | 23 (32.39) | 29.6817 |
| 2010's | 18 (25.35) | 24.3611 |
| 2020's | 2 (2.82) | 2.80 |
| Authors | Studies |
|---|---|
| Fernandez, A | 1 |
| Pendaries, G | 1 |
| Dor, E | 1 |
| Askenazy, F | 1 |
| Thümmler, S | 1 |
| Martin, M | 1 |
| Ureste, P | 1 |
| Cole, JB | 1 |
| Klein, LR | 1 |
| Mullinax, SZ | 1 |
| Nordstrom, KD | 1 |
| Driver, BE | 1 |
| Wilson, MP | 1 |
| Quinn, DK | 1 |
| Rees, C | 1 |
| Brodsky, A | 1 |
| Deligtisch, A | 1 |
| Evans, D | 1 |
| Khafaja, M | 1 |
| Abbott, CC | 1 |
| Cristancho, P | 1 |
| Jewkes, D | 1 |
| Mon, T | 1 |
| Conway, C | 1 |
| Lee, SY | 1 |
| Chen, SL | 1 |
| Chang, YH | 1 |
| Chen, PS | 1 |
| Huang, SY | 2 |
| Tzeng, NS | 2 |
| Wang, CL | 1 |
| Wang, LJ | 1 |
| Lee, IH | 1 |
| Wang, TY | 1 |
| Chen, KC | 1 |
| Yang, YK | 1 |
| Hong, JS | 1 |
| Lu, RB | 2 |
| van Ham, C | 1 |
| Schrijvers, D | 1 |
| De Picker, L | 1 |
| Vandendriessche, F | 1 |
| Sabbe, B | 1 |
| Barnhorst, A | 1 |
| Xiong, GL | 1 |
| Chou, PH | 1 |
| Ouyang, WC | 1 |
| Lan, TH | 1 |
| Chan, CH | 1 |
| Ford, N | 1 |
| Ludbrook, G | 1 |
| Galletly, C | 1 |
| Ballin, NH | 1 |
| Pagsberg, AK | 1 |
| Lin, CC | 1 |
| Hung, YY | 1 |
| Tsai, MC | 1 |
| Huang, TL | 1 |
| Knapen, SE | 1 |
| Riemersma-van der Lek, RF | 1 |
| Haarman, BC | 1 |
| Schoevers, RA | 1 |
| Önen, Ö | 1 |
| Kutlu, A | 1 |
| Erkuran, HÖ | 1 |
| Mazza, M | 1 |
| Squillacioti, MR | 1 |
| Pecora, RD | 1 |
| Janiri, L | 1 |
| Bria, P | 1 |
| Kruszewski, SP | 1 |
| Paczynski, R | 1 |
| Hardy, D | 1 |
| Sekhar, S | 1 |
| Kalra, B | 1 |
| Mendhekar, DN | 1 |
| Tekur, U | 1 |
| Lynch, MJ | 1 |
| Pizon, AF | 1 |
| Siam, MG | 1 |
| Krasowski, MD | 1 |
| Binbay, T | 1 |
| Danivas, V | 1 |
| Behere, RV | 1 |
| Varambally, S | 1 |
| Rao, NP | 1 |
| Venkatasubramanian, G | 1 |
| Gangadhar, BN | 1 |
| Hung Chi, M | 1 |
| Hua Chang, H | 1 |
| Chou, KR | 1 |
| Chun Tsai, H | 1 |
| Kuang Yang, Y | 1 |
| See Chen, P | 1 |
| Jacobowski, NL | 1 |
| Heckers, S | 1 |
| Bobo, WV | 1 |
| Yatham, LN | 1 |
| Grossman, F | 2 |
| Augustyns, I | 1 |
| Vieta, E | 2 |
| Ravindran, A | 1 |
| Battaglia, J | 1 |
| Lindborg, SR | 1 |
| Alaka, K | 1 |
| Meehan, K | 2 |
| Wright, P | 1 |
| Coffey, B | 1 |
| Curtin, F | 1 |
| Schulz, P | 1 |
| Smulevich, AB | 1 |
| Khanna, S | 1 |
| Eerdekens, M | 1 |
| Karcher, K | 1 |
| Kramer, M | 1 |
| Mamah, D | 1 |
| Hong, BA | 1 |
| Chapman, WC | 1 |
| Pruett, JR | 1 |
| Rizvi, ST | 1 |
| Lewin, MR | 1 |
| Montauk, L | 1 |
| Shalit, M | 1 |
| Nobay, F | 1 |
| Sheehan, W | 1 |
| Thurber, S | 1 |
| McDaniel, WW | 1 |
| Spiegel, DR | 1 |
| Sahota, AK | 1 |
| Zimbroff, DL | 2 |
| Marcus, RN | 2 |
| Manos, G | 2 |
| Stock, E | 1 |
| McQuade, RD | 2 |
| Auby, P | 1 |
| Oren, DA | 1 |
| Currier, GW | 1 |
| Citrome, LL | 1 |
| Oren, D | 1 |
| McQuade, R | 1 |
| Pikalov, AA | 1 |
| Crandall, DT | 1 |
| Rodriguez, LJ | 1 |
| Keck, PE | 3 |
| Calabrese, JR | 1 |
| McIntyre, RS | 1 |
| Carson, WH | 1 |
| Eudicone, JM | 1 |
| Carlson, BX | 1 |
| Sanchez, R | 1 |
| Miller, MA | 1 |
| Levsky, ME | 1 |
| Dunn, RT | 1 |
| Stan, VA | 1 |
| Chriki, LS | 1 |
| Filkowski, MM | 1 |
| Ghaemi, SN | 1 |
| Cruz, N | 1 |
| García-Campayo, J | 1 |
| de Arce, R | 1 |
| Manuel Crespo, J | 1 |
| Vallès, V | 1 |
| Pérez-Blanco, J | 1 |
| Roca, E | 1 |
| Manuel Olivares, J | 1 |
| Moríñigo, A | 1 |
| Fernández-Villamor, R | 1 |
| Comes, M | 1 |
| Fouks, L | 1 |
| Widlocher, D | 1 |
| Lecrubier, Y | 1 |
| Le Goc, Y | 1 |
| Galynker, II | 1 |
| Rosenthal, RN | 1 |
| Perkel, C | 1 |
| Shwartz, A | 1 |
| McElroy, SL | 2 |
| Tugrul, KC | 1 |
| Bennett, JA | 1 |
| Finnerty, M | 1 |
| Levin, Z | 1 |
| Miller, LJ | 1 |
| Lisanby, SH | 1 |
| Devanand, DP | 1 |
| Nobler, MS | 1 |
| Prudic, J | 1 |
| Mullen, L | 1 |
| Sackeim, HA | 1 |
| Liu, CY | 1 |
| Wang, SJ | 1 |
| Fuh, JL | 1 |
| Yang, YY | 1 |
| Liu, HC | 1 |
| Post, RM | 1 |
| Ketter, TA | 1 |
| Denicoff, K | 1 |
| Pazzaglia, PJ | 1 |
| Leverich, GS | 1 |
| Marangell, LB | 1 |
| Callahan, AM | 1 |
| George, MS | 1 |
| Frye, MA | 1 |
| Rosenfeld, MJ | 1 |
| Friedman, JH | 1 |
| Chou, JC | 1 |
| Czobor, P | 1 |
| Charles, O | 1 |
| Tuma, I | 1 |
| Winsberg, B | 1 |
| Allen, MH | 1 |
| Trujillo, M | 1 |
| Volavka, J | 1 |
| Zhang, F | 1 |
| David, S | 1 |
| Tohen, M | 1 |
| Janicak, P | 1 |
| Small, J | 1 |
| Koch, M | 1 |
| Rizk, R | 1 |
| Walker, D | 1 |
| Tran, P | 1 |
| Breier, A | 1 |
| Kafantaris, V | 1 |
| Coletti, DJ | 1 |
| Dicker, R | 1 |
| Padula, G | 1 |
| Kane, JM | 1 |
| Kerbusch, T | 1 |
| Mathôt, RA | 1 |
| Otten, HM | 1 |
| Meesters, EW | 1 |
| van Kan, HJ | 1 |
| Schellens, JH | 1 |
| Beijnen, JH | 1 |
| Singer, L | 1 |
| Finance, MF | 1 |
| Ruh, MD | 1 |
| Lenox, RH | 3 |
| Newhouse, PA | 1 |
| Creelman, WL | 1 |
| Whitaker, TM | 1 |
| Pope, HG | 1 |
| Hudson, JI | 1 |
| Bradwejn, J | 1 |
| Shriqui, C | 1 |
| Koszycki, D | 1 |
| Meterissian, G | 1 |
| Salzman, C | 1 |
| Miyawaki, EK | 1 |
| Soloman, D | 1 |
| Yassa, R | 1 |
| Groulx, B | 1 |
| Santos, AB | 1 |
| Morton, WA | 1 |
| Rigby, J | 1 |
| Harvey, M | 1 |
| Davies, DR | 1 |
| Jobling, M | 1 |
| Stein, G | 1 |
| Chouinard, G | 1 |
| Dever, A | 1 |
| Schweizer, E | 1 |
| Cohen, S | 1 |
| Khan, A | 1 |
| Burke, WJ | 1 |
| Lapierre, YD | 1 |
| Labelle, A | 1 |
| Majeau-Chargois, D | 1 |
| Goodman, WK | 1 |
| Charney, DS | 1 |
| Modell, JG | 2 |
| Weiner, S | 2 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Observational Study of Anti-Psychotic Medication for the Treatment of Agitation in the Emergency Department[NCT02877108] | 100 participants (Anticipated) | Observational | 2016-04-30 | Recruiting | |||
| Double Blind Placebo Controlled Trial of a Protein Kinase C Inhibitor: Tamoxifen Citrate in Treatment of Acute Mania[NCT00411203] | Phase 3 | 66 participants (Actual) | Interventional | 2003-04-30 | Completed | ||
| The Safety And Efficacy Of Risperdal� (Risperidone) Versus Placebo As Add-On Therapy To Mood Stabilizers In The Treatment Of The Manic Phase Of Bipolar Disorder[NCT00250367] | Phase 3 | 151 participants (Actual) | Interventional | 1997-10-31 | Completed | ||
| The Efficacy And Safety Of Flexible Dose Ranges Of Risperidone Versus Placebo Or Haloperidol In The Treatment Of Manic Episodes Associated With Bipolar I Disorder.[NCT00253162] | Phase 3 | 439 participants (Actual) | Interventional | 2001-03-31 | Completed | ||
| [NCT00036348] | Phase 3 | 0 participants | Interventional | 2000-03-31 | Completed | ||
| A Multi-center, Randomized, Double-blind, Parallel Group, Placebo-controlled 52 Weeks Clinical Trial to Evaluate Efficacy and Safety of Oxcarbazepine p.o.(300-1200 mg/Day) as Adjuvant Therapy in the Bipolar Disorder I or II Treatment[NCT00154323] | Phase 4 | 55 participants (Actual) | Interventional | 2003-01-31 | Completed | ||
| Effect of Bupropion on Seizure Threshold in Depressed Patients[NCT03126682] | Phase 4 | 10 participants (Actual) | Interventional | 2017-08-25 | Completed | ||
| Treatment and Outcome of Early Onset Bipolar Disorder[NCT00048802] | Phase 4 | 40 participants | Interventional | 2002-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Scoring of depressive symptoms on the Montgomery Asberg Depression Rating Scale, maximum 60 , minimum 0. Higher scores mean worse outcome. First measurement on day 1 of electroconvulsive treatment (ECT) and second measurement on day 2 of electroconvulsive therapy (ECT), separated by 1 day interval. This outcome measure was not measured at baseline. (NCT03126682)
Timeframe: Scored on day 1 and day 2 after ECT session
| Intervention | Scored on a scale (Mean) |
|---|---|
| Wellbutrin During ECT 1 | 2.60 |
| Wellbutrin During ECT 2 | 3.60 |
Duration of seizures with ECT. First measurement on day 1 of electroconvulsive treatment (ECT) and second measurement on day 2 of electroconvulsive therapy (ECT), separated by 1 day interval. This outcome measure was not measured at baseline. (NCT03126682)
Timeframe: Measured at day 1 and day 2
| Intervention | seconds (Mean) |
|---|---|
| Wellbutrin During ECT 1 | 26.2 |
| Wellbutrin During ECT 2 | 29.6 |
Charge in Millicoulombs at which subject gets a seizure with ECT. First measurement on day 1 of electroconvulsive treatment (ECT) and second measurement on day 2 of electroconvulsive therapy (ECT), separated by 1 day interval. This outcome measure was not measured at baseline. (NCT03126682)
Timeframe: Measured at day 1 and day 2
| Intervention | millicoulombs (Mean) |
|---|---|
| Wellbutrin During ECT 1 | 23.04 |
| Wellbutrin During ECT 2 | 19.68 |
4 reviews available for lorazepam and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
Electroconvulsive therapy use in the adult U.S. correctional setting: A case report and literature review.
Topics: Bipolar Disorder; Catatonia; Creatine Kinase; Electroconvulsive Therapy; Health Services Accessibili | 2021 |
Delirious mania: detection, diagnosis, and clinical management in the acute setting.
Topics: Bipolar Disorder; Catatonia; Delirium; Electroconvulsive Therapy; Humans; Hypnotics and Sedatives; L | 2013 |
Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis.
Topics: Bayes Theorem; Bipolar Disorder; Clonazepam; GABA Modulators; Humans; Lorazepam; Placebos; Randomize | 2004 |
The place of anticonvulsant therapy in bipolar illness.
Topics: Affect; Anticonvulsants; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Clonazepam; Drug | 1996 |
19 trials available for lorazepam and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
Correlation of plasma brain-derived neurotrophic factor and metabolic profiles in drug-naïve patients with bipolar II disorder after a twelve-week pharmacological intervention.
Topics: Adult; Affect; Bipolar Disorder; Body Mass Index; Brain-Derived Neurotrophic Factor; Cholesterol; Fe | 2015 |
Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Ag | 2008 |
Efficacy of sodium valproate and haloperidol in the management of acute mania: a randomized open-label comparative study.
Topics: Adolescent; Adult; Antimanic Agents; Bipolar Disorder; Dyskinesia, Drug-Induced; Female; Haloperidol | 2010 |
Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial.
Topics: Adult; Aged; Antimanic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Brief | 2003 |
Calming versus sedative effects of intramuscular olanzapine in agitated patients.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dementia; Doubl | 2003 |
Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Bipolar Disorder; Dopamine Antagonists; Double-Blind | 2005 |
Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dis | 2007 |
Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depression; Diagnostic and Statistical | 2007 |
A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression.
Topics: Acute Disease; Adolescent; Adult; Akathisia, Drug-Induced; Ambulatory Care; Antidepressive Agents; A | 2008 |
A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combina | 2008 |
Valproate oral loading in the treatment of acute mania.
Topics: Acute Disease; Administration, Oral; Adult; Bipolar Disorder; Drug Therapy, Combination; Female; Hos | 1993 |
Acute mania: haloperidol dose and augmentation with lithium or lorazepam.
Topics: Adult; Aged; Anti-Anxiety Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Citrates | 1999 |
A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania.
Topics: Adult; Affect; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Choline | 2001 |
Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study.
Topics: Adult; Aged; Aggression; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; H | 1992 |
Valproate in the treatment of acute mania. A placebo-controlled study.
Topics: Acute Disease; Adolescent; Adult; Aged; Bipolar Disorder; Double-Blind Method; Drug Administration S | 1991 |
Double-blind comparison of the effects of clonazepam and lorazepam in acute mania.
Topics: Acute Disease; Adult; Bipolar Disorder; Clonazepam; Double-Blind Method; Drug Therapy, Combination; | 1990 |
Use of benzodiazepines.
Topics: Bipolar Disorder; Clinical Trials as Topic; Humans; Lorazepam; Psychomotor Agitation | 1990 |
Use of benzodiazepines to improve management of manic agitation.
Topics: Bipolar Disorder; Clinical Trials as Topic; Clonazepam; Drug Administration Schedule; Humans; Loraze | 1989 |
The use of benzodiazepines in the treatment of manic-depressive illness.
Topics: Acute Disease; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Basal Ga | 1988 |
48 other studies available for lorazepam and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
[Malignant neuroleptic syndrome: An atypical case in an adolescent affected by bipolar I disorder associated with catatonic syndrome].
Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Catatonia; Electroencephalography; Humans; Hypno | 2020 |
Study Enrollment When "Preconsent" Is Utilized for a Randomized Clinical Trial of Two Treatments for Acute Agitation in the Emergency Department.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Emergency Service, Hospital; Ethics, Research; Female | 2019 |
Catatonia after deep brain stimulation successfully treated with lorazepam and right unilateral electroconvulsive therapy: a case report.
Topics: Aged; Anti-Anxiety Agents; Bipolar Disorder; Catatonia; Combined Modality Therapy; Deep Brain Stimul | 2014 |
Successful use of right unilateral ECT for catatonia: a case series.
Topics: Adolescent; Adult; Aged, 80 and over; Antipsychotic Agents; Bipolar Disorder; Catatonia; Depressive | 2014 |
Neuropsychiatric features in Behçet's disease: a case report.
Topics: Adult; Antipsychotic Agents; Behcet Syndrome; Bipolar Disorder; Brain; Butyrophenones; Diagnostic an | 2014 |
Pulmonary embolism in a psychiatric patient.
Topics: Adult; Aggression; Antipsychotic Agents; Autopsy; Benzodiazepines; Bipolar Disorder; Catatonia; Deat | 2014 |
Secondary mania due to AIDS and cryptococcal meningitis in a 78-year-old patient.
Topics: Aged; AIDS-Related Opportunistic Infections; Antipsychotic Agents; Bipolar Disorder; Cryptococcus ne | 2016 |
Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; De | 2015 |
[Catatonia is often overlooked in child and adolescent psychiatry].
Topics: Adolescent; Adolescent Psychiatry; Anticonvulsants; Bipolar Disorder; Catatonia; Child Psychiatry; H | 2016 |
Relapses and recurrences of catatonia: 30-case analysis and literature review.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Catatonia; Clozapine; Depressive Disorder | 2016 |
Coping with a life event in bipolar disorder: ambulatory measurement, signalling and early treatment.
Topics: Adaptation, Psychological; Adult; Ambulatory Care; Bipolar Disorder; Female; Humans; Hypnotics and S | 2016 |
Treating an Adolescent with Long QT Syndrome for Bipolar Disorder: A Case Presentation.
Topics: Adolescent; Bipolar Disorder; Female; Humans; Long QT Syndrome; Lorazepam; Risperidone; Valproic Aci | 2017 |
Concomitant use of Lorazepam with tamoxifen in bipolar mania clinical trials.
Topics: Anticonvulsants; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Humans; Lorazepam | 2009 |
You're the flight surgeon: a psychiatric patient in a combat zone.
Topics: Adult; Air Ambulances; Anti-Anxiety Agents; Bipolar Disorder; Humans; Iraq War, 2003-2011; Lorazepam | 2009 |
Clinical effects and toxicokinetic evaluation following massive topiramate ingestion.
Topics: Acidosis; Adult; Anticonvulsants; Bipolar Disorder; Blood Gas Analysis; Coma; Critical Care; Drug Ov | 2010 |
[First-episode mania with psychotic features induced by over-the-counter diet aids containing sibutramine].
Topics: Appetite Depressants; Bipolar Disorder; Cyclobutanes; Humans; Hypnotics and Sedatives; Lorazepam; No | 2010 |
Electroconvulsive therapy in the treatment of delirious mania: a report of 2 patients.
Topics: Adolescent; Antimanic Agents; Bipolar Disorder; Catatonia; Delirium; Electroconvulsive Therapy; Fema | 2010 |
The prevalence of metabolic syndrome in drug-naïve bipolar II disorder patients before and after twelve week pharmacological intervention.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Body Mass Index; Diagnostic and Statistical Manual of Men | 2013 |
Clinical case presentation: therapeutic challenges in adolescent-onset bipolar disorder.
Topics: Adolescent; Aggression; Anti-Anxiety Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorde | 2003 |
Liver transplantation in a patient with undiagnosed bipolar disorder.
Topics: Bipolar Disorder; Female; Hepatitis C; Humans; Liver Diseases, Alcoholic; Liver Transplantation; Lor | 2004 |
A16-year-old girl with excited catatonia treated with low-dose oral Lorazepam.
Topics: Adolescent; Bipolar Disorder; Catatonia; Delirium; Dose-Response Relationship, Drug; Female; Humans; | 2005 |
An unusual case of subterfuge in the emergency department: covert administration of antipsychotic and anxiolytic medications to control an agitated patient.
Topics: Administration, Oral; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Beverages; Bipolar Disorder; | 2006 |
SPECT and neuropsychological measures of lithium toxicity.
Topics: Aged; Antimanic Agents; Bipolar Disorder; Brain; Cerebellum; Dibenzothiazepines; Dose-Response Relat | 2006 |
Topiramate effect in catatonia: a case series.
Topics: Adult; Aged; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Cataplexy; Catatonia; Dose-Res | 2006 |
Intramuscular aripiprazole in the control of agitation.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Arousal; Bipolar Disorder; Dose-Response Relationship, Dr | 2007 |
A closer look: the benefits and effectiveness of cognitive behavioral therapy on a female-specific unit for treatment of bipolar disorder.
Topics: Adult; Bipolar Disorder; Cognitive Behavioral Therapy; Female; Health Knowledge, Attitudes, Practice | 2007 |
Choreiform dyskinesia following isolated lamotrigine overdose.
Topics: Adult; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Chorea; Drug Overdose; Dyskinesia, Drug- | 2008 |
[Lorazepam. Evaluation after extensive use].
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Bipolar Disorder; Depressive Disorder; Dogs; Humans | 1981 |
The place of anxiety in depressive symptomatology.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Bipolar Disorder; Clorazepate Dipotas | 1983 |
Doxepin withdrawal mania.
Topics: Bipolar Disorder; Doxepin; Drug Therapy, Combination; Female; Humans; Lithium; Lorazepam; Middle Age | 1995 |
Acute manic episodes in pregnancy.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Comorbidity; Diabetes Mellitus, Type 1; Drug Therapy, Combi | 1996 |
Exceptionally high seizure threshold: ECT device limitations.
Topics: Aged; Aged, 80 and over; Anti-Anxiety Agents; Bipolar Disorder; Depressive Disorder; Electroconvulsi | 1996 |
Bipolar disorder following a stroke involving the left hemisphere.
Topics: Bipolar Disorder; Cerebral Infarction; Dominance, Cerebral; Drug Therapy, Combination; Haloperidol; | 1996 |
Catatonia responsive to lorazepam: a case report.
Topics: Aged; Bipolar Disorder; Catatonia; Diagnosis, Differential; Female; Hip Fractures; Humans; Lorazepam | 1999 |
Adjunctive antipsychotic treatment of adolescents with bipolar psychosis.
Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Child; Drug Therapy, Combination; Female; Humans | 2001 |
Bayesian pharmacokinetics of lithium after an acute self-intoxication and subsequent haemodialysis: a case report.
Topics: Acute Disease; Acute Kidney Injury; Adult; Antimanic Agents; Antipsychotic Agents; Bayes Theorem; Bi | 2002 |
[Pulmonary embolisms occurring in 1 month in 3 aged women with manic-depressive psychoses. Discussion. Etiopathogenic role or psychiatric treatment].
Topics: Aged; Antidepressive Agents; Bipolar Disorder; Chlorpromazine; Clomipramine; Depressive Disorder, Ma | 1975 |
Lorazepam in the treatment of lithium-induced akathisia.
Topics: Akathisia, Drug-Induced; Bipolar Disorder; Drug Therapy, Combination; Humans; Lithium; Lithium Carbo | 1989 |
Mania precipitated by benzodiazepine withdrawal.
Topics: Aged; Aged, 80 and over; Bipolar Disorder; Cyclothymic Disorder; Female; Humans; Lorazepam; Mood Dis | 1989 |
Lorazepam in resistant mania.
Topics: Bipolar Disorder; Humans; Lorazepam; Male; Middle Aged | 1986 |
Rapid remission of organic mania after treatment with lorazepam.
Topics: Bipolar Disorder; Female; Humans; Lorazepam; Middle Aged; Neurocognitive Disorders | 1988 |
Respiratory distress with use of lorazepam in mania.
Topics: Adult; Bipolar Disorder; Female; Humans; Lorazepam; Respiratory Insufficiency | 1987 |
Benzodiazepine-induced hypomania?
Topics: Bipolar Disorder; Humans; Lorazepam; Male; Middle Aged | 1987 |
Manic-like reaction induced by lorazepam withdrawal.
Topics: Anxiety Disorders; Bipolar Disorder; Female; Humans; Lorazepam; Middle Aged; Sleep Initiation and Ma | 1987 |
Lorazepam and manic agitation.
Topics: Adult; Bipolar Disorder; Humans; Lorazepam; Male; Myocardial Infarction; Psychomotor Agitation | 1986 |
A case of alprazolam, but not lorazepam, inducing manic symptoms.
Topics: Adult; Alprazolam; Anxiety Disorders; Bipolar Disorder; Female; Humans; Lorazepam; Panic | 1987 |
Acute treatment of manic agitation with lorazepam.
Topics: Acute Disease; Bipolar Disorder; Humans; Injections, Intramuscular; Lorazepam; Psychomotor Agitation | 1986 |
Inpatient clinical trial of lorazepam for the management of manic agitation.
Topics: Adult; Ataxia; Bipolar Disorder; Delirium; Female; Humans; Lorazepam; Male; Middle Aged; Mood Disord | 1985 |